See also this year's filing and all EDGAR filings for this company.
PDF Report 0001408443_2023_Milestone_Pharmaceuticals_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001408443', 'EntityCommonStockSharesOutstanding': 33287226, 'Assets': 74483000, 'AssetsCurrent': 71803000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 8135000, 'LiabilitiesAndStockholdersEquity': 74483000, 'LiabilitiesCurrent': 6139000, 'LiabilitiesNoncurrent': 1996000, 'NetIncome': -58388000, 'PropertyPlantAndEquipmentNet': 257000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 2423000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 66348000, 'remainder_NetIncome': -58388000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001408443')"} |
Edgar->Model Mapping
